R&D expense · 2011–2025
Myriad Genetics R&D expense
$107M−5.8% · FY2025
Myriad Genetics (MYGN) reported $107M in R&D expense for fiscal 2025, −5.8% year on year.
| Fiscal year | R&D expense | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $107M | −5.8% | Open → |
| FY20242024-12-31 | $113M | +27.8% | Open → |
| FY20232023-12-31 | $88.7M | +3.9% | Open → |
| FY20222022-12-31 | $85.4M | +4.3% | Open → |
| FY20212021-12-31 | $81.9M | +11.7% | Open → |
| FY20202020-12-31 | $73.3M | −14.7% | Open → |
| FY20192019-06-30 | $85.9M | +21.3% | Open → |
| FY20182018-06-30 | $70.8M | −4.8% | Open → |
| FY20172017-06-30 | $74.4M | +5.4% | Open → |
| FY20162016-06-30 | $70.6M | −6.5% | Open → |
| FY20152015-06-30 | $75.5M | +11.9% | Open → |
| FY20142014-06-30 | $67.5M | +25.7% | Open → |
| FY20132013-06-30 | $53.7M | +25.9% | Open → |
| FY20122012-06-30 | $42.6M | +53.7% | Open → |
| FY20112011-06-30 | $27.8M | — | Open → |
R&D expense — Research and development expense is what the company charged to R&D in the income statement for the year. Most companies report no R&D at all — the line is absent rather than zero — so this ranking covers the roughly 40% of filers that do.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +10.1%
R&D expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Myriad Genetics R&D expense |url=https://companiesranked.com/en/company/myriad-genetics/research-and-development-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Myriad Genetics R&D expense. CompaniesRanked. https://companiesranked.com/en/company/myriad-genetics/research-and-development-expenseBibTeX
@misc{companiesranked-en-company-myriad-genetics-research-and-development-expense-2026,
author = {{CompaniesRanked}},
title = {{Myriad Genetics R\&D expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/myriad-genetics/research-and-development-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0000899923-26-000018 · February 24, 2026
{{cite web |title=Myriad Genetics R&D expense — 10-K (0000899923-26-000018) |url=https://www.sec.gov/Archives/edgar/data/899923/000089992326000018/mygn-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-24}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.